
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Journal
- Events
- Suppliers
- Home
- Industry news
Industry news
- Category news
Category news
- Reports
- Key trends
- Multimedia
- Events
- Suppliers
Perrigo’s Chairman and CEO Joseph C. Papa stated, “We are excited to receive FDA clearance on these new liquid concentrate and ready-to-use products and to expand our portfolio of non-powder infant formula products.
Aug 27 2010 --- Perrigo Company announced it received FDA clearance on August 23, 2010 to manufacture infant formula liquid concentrate and ready-to-use products through its partner Kerry Proteins and Nutritionals located in Sainte Claire, Quebec. Perrigo received clearance to market the following new products:
-Milk-Based Infant Formula with ARA and DHA, Concentrate in a 13 oz multilayer high-barrier polypropylene bottle
-Milk-Based Infant Formula with ARA and DHA, Ready-to-Use Infant Formula in an 8 oz multilayer high-barrier polypropylene bottle
-Milk-Based Organic Infant Formula with ARA/DHA, Liquid Ready-to-Feed Infant Formula in an 8 oz multilayer high-barrier polypropylene bottle
Perrigo’s Chairman and CEO Joseph C. Papa stated, “We are excited to receive FDA clearance on these new liquid concentrate and ready-to-use products and to expand our portfolio of non-powder infant formula products. This is the first launch of new products since acquiring our infant nutrition business and we look forward to further new product introductions.”











